Efficacy of Internet-delivered Trauma-focused CBT for Young People With PTSD

Posttraumatic Stress Disorder Clinical Trial

Official title:

Efficacy and Cost Effectiveness of Internet-delivered Trauma-focused CBT for Young People With PTSD

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06185244
• Other study ID #: 2023-06501-01
• Status: Recruiting
• Phase: N/A
• Start date: March 11, 2024
• Est. completion date: January 4, 2028

Study information

• Verified date: March 2024
• Source: Karolinska Institutet
• Contact: Maria Bragesjö
• Phone: +46(0)703399387
• Email: maria.bragesjo[@]ki.se
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The goal of this clinical trial is to compare therapist-guided internet delivered trauma-focused cognitive behavior therapy (CBT) to an active control condition comprising therapist-guided internet delivered cognitive behavioral therapy containing relaxation techniques and psychoeducation for young people with post-traumatic stress disorder regarding efficacy and cost effectiveness. Young people with post-traumatic stress disorder will be randomly assigned to receive either 12 weeks of therapist-guided internet delivered trauma-focused cognitive behavior therapy (iTF-CBT) or therapist-guided internet delivered cognitive-behavioral therapy containing relaxation and psychoeducation.

Description:

There is an urgent need for evidence-based treatments for children with PTSD that can easily be made available to a large number of afflicted. The overall aim of the project is to increase the availability of evidence-based psychological treatments for adolescents with PTSD by developing and evaluating iTF-CBT for this target group. The main objectives are to establish the efficacy, cost-effectiveness, and long-term effects of iTF-CBT for adolescents with PTSD in an RCT (N=140) by comparing guided iTF-CBT with an attention control group consisting of therapist-supported internet-delivered psychoeducation and support. The study is a single-blind, parallel-group superiority randomized controlled trial with 240 patients (120 per arm) that will compare therapist-guided internet delivered trauma-focused cognitive behavior CBT with therapist-guided internet delivered cognitive-behavioral therapy comprising relaxation and psychoeducation. The primary outcome is the blind-rater administered Clinician-Administered PTSD Scale for DSM-5 (CAPS-5-CA). An internal pilot is built in in the design and the first 20 enrolled participants will not be randomized but receive the active intervention. They will also be asked to participate in qualitative interviews about their experience of the intervention. Secondary outcomes are cost effectiveness, predictors of clinically meaningful change in symptoms, mediators of change, dropout rate, and negative effects. Research questions: 1. Is guided iTF-CBT more efficacious than an active control condition (therapist-supported internet-delivered psychoeducation and support) in regard to reduction of blinded assessor rated PTSD symptom severity 1-month post-treatment? 2. Is guided iTF-CBT more cost-effective than an active control condition (therapist-supported internet-delivered psychoeducation and support) in regard to reduction of blinded assessor rated PTSD symptom severity 1-month post-treatment? 3. Are the therapeutic gains of iTF-CBT maintained at long term follow up (6 and 12 months after treatment)? 4. How do children, parents and therapists perceive iTF-CBT?

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 240
• Est. completion date: January 4, 2028
• Est. primary completion date: January 4, 2027
• Accepts healthy volunteers: No
• Gender: All
• Age group: 13 Years to 17 Years

Eligibility

Inclusion Criteria:

• 13-17 years,
• Primary PTSD diagnosis
• Fluent in Swedish
• Access to the Internet at home or can use vouchers for internet-access to their phone.
• Parent/guardian willing and able to take part in treatment.

Exclusion Criteria:

• PTSD is not the primary concern
• Initiation or adjustment of any psychotropic medication within the last 4 weeks prior to commencement of treatment
• Serious mental health symptoms, such as mania, psychosis, alcohol, or substance use disorders or current suicide risk warranting immediate clinical attention.
• Ongoing trauma-focused CBT or Eye movement desensitization and reprocessing Therapy
• Ongoing trauma-related threat

Related Conditions & MeSH terms

• Posttraumatic Stress Disorder
• Stress Disorders, Post-Traumatic

Intervention

Behavioral:
• Therapist-supported internet-delivered trauma-focused CBT
12 weeks of therapist-supported internet-delivered trauma-focused CBT for both the youth and the care giver.
• 12 weeks of therapist-supported internet-delivered psychoeducation and stress management/relaxation for both the youth and the care giver.
12 weeks of therapist-supported internet-delivered psychoeducation and stress management/relaxation for both the youth and the care giver.

Locations

Country	Name	City	State
Sweden	Barn och ungdomspsykiatrin, BUP Internetenhet and Save the Children	Stockholm

Sponsors (3)

Lead Sponsor	Collaborator
Karolinska Institutet	Child and Adolescent Psychiatry, Stockholm, Save the Children

Country where clinical trial is conducted

Sweden, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Differences in treatment credibility between arms	Measures treatment expectancy and rationale credibility. The CEQ is a 5-item measure of the treatment's credibility and the patients' expectations. The patients assess each domain on a 11-point likert scale (scored 0-10), with a total score ranging between 0-50 where higher score indicates higher credibility and higher expectations.	After completion of the first treatment module (week 1 from baseline)
Other	Differences in experience of working alliance between arms	Measures the therapeutic alliance in therapy. The WAI-SR is a 12-item measure of the patient's experience of their working alliance with the therapist. The patients assess each item on a 7-point likert scale (scored 0-6), with a total score ranging between 0-72 where higher score indicates higher better working alliance according to the patient.	After completion of the third module (week 3 from baseline)
Primary	Change in PTSD symptoms as assessed by the Clinician Administered PTSD Scale Children and Adolescent version 5 (CAPS-5-CA)	The CAPS-5-CA is a structured interview that assesses the Diagnostic and Statistical Manual of Mental Disorders version 5 (DSM-5) criteria for PTSD (Weathers et al., 2013). Each item is rated on a severity scale ranging from 0 (Absent) to 4 (Extreme/incapacitating) and combines information about frequency and intensity for each of the 20 symptoms. Total Score (Range 0-80 with higher scores representing more PTSD symptoms.	Baseline, 1-month (primary endpoint), 6-month and 12-month after treatment completion
Secondary	Change in self-rated symptoms of PTSD and complex PTSD measured by The Child and Adolescent Trauma Screen (CATS-2)	The CATS-2 measures potentially traumatic events (PTEs), posttraumatic stress symptoms (PTSS) and impairment according to DSM-5 and ICD-11 criteria in children and adolescent from 7 to 17 years. In addition to a self-report measure for children and adolescents, the CATS-2 includes a parallel caregiver version. Posttraumatic stress symptoms in the last four weeks are then assessed using 25 items rated on a 4-point. The 25 items map directly onto the diagnostic criteria for PTSD in DSM-5 and ICD-11 PTSD and CPTSD. The DSM-5 PTSD severity score is the sum of items 1-20 (range 0-60), including only the highest score of items 9, 10, 15. The ICD-11 PTSD severity score (range 0-18) is the sum of items 2, 3, 6, 7, 17, 18. The ICD-11 CPTSD score (range 0-36) is the sum of ICD-11 PTSD severity score (2, 3, 6, 7, 17, 18) plus the sum of the ICD-11 DSO severity score (9b, 9d, 10a, 13, 14, 15a). Higher scores represents more PTSD symptoms.	Baseline, through the treatment period up to 12 weeks and 1-month, 6-month and 12-month after treatment completion
Secondary	Change in self-rated symptoms of depression as measured by Mood and Feelings Questionnaire (MFQ)	The MFQ consists of a series of 33 descriptive phrases regarding how the subject has been feeling or acting recently. Respondents are asked whether descriptions in the questionnaire are 'true', 'sometimes true' or 'not true' for them over the past two weeks. The MFQ is scored by summing together the point values of responses for each item. The response choices and their designated point values are as follows: "not true" = 0 points, "sometimes true" = 1 point, "true" = 2 points. Higher scores on the MFQ suggest more severe depressive symptoms.	Baseline, immediately after treatment completion, and 1-month, 6-month and 12-month after treatment completion
Secondary	Change in psychosocial impairment measured by The Education, Work and Social Adjustment Scale, Youth and Parent (EWSAS)	EWSAS is a short, self-reported instrument consisting of five items about psychosocial impairments rated on a nine-point Likert scale. A higher score means more severe impairment.	Baseline, immediately after treatment completion, and 1-month, 6-month and 12-month after treatment completion
Secondary	Change in Treatment Inventory of Costs in Psychiatric Patients (TIC-P)	Self-rated questionnaire on healthcare utilization and productivity losses in patients with a psychiatric disorder. The TIC-P questionnaire measures costs in two dimensions: use of health resources and loss of productivity. Lower cost is better.	Baseline, immediately after treatment completion, and 1-month, 6-month and 12-month after treatment completion
Secondary	Adverse events related to treatment measured by the Negative effects questionnaire	Self-rated questionnaire on negative effects. It contains 32 items that are scored on a five point Likert-scale (0-4) and differentiates between negative effects that are attributed to treatment and those possibly caused by other circumstances. The total score of the NEQ ranges from 0 to 80 points, a higher score reflects more negative effects.	Immediately after treatment completion, 1-month, 6-month and 12-month after treatment completion
Secondary	Quality of life measured by Assessment of Quality of Life KIDSCREEN-10	Change in subjective psychological, mental and social well-being from baseline to immediately after treatment and follow up . a higher score reflects higher health-related quality of life.	Immediately after treatment completion, 1-month, 6-month and 12-month after treatment completion
Secondary	Participants satisfaction with treatment, assessed by The Client Satisfaction Questionnaire (CSQ-8).	The CSQ-8 yields a single score measuring a single dimension of overall satisfaction. An "overall score" is calculated by summing the score on each of the eight scale item. Scores range from 8 to 32, with higher values indicating higher satisfaction.	Immediately after treatment completion.
Secondary	Number of completed treatment modules	Data will be gathered on total number of completed modules during the 12 week treatment.	Baseline up to 12 weeks
Secondary	Number of messages sent and received in the digital platform	Data will be gathered on total number of messages sent and received back and forth between the participant and the therapist during the 12 week treatment.	Baseline up to 12 weeks
Secondary	Number of home work assignments made by the participant during the treatment period	umber of home work assignments made by the participant during the treatment period	up to 12 weeks
Secondary	The proportion of participants that conducts the weekly measures and further assessment points	The proportion of participants that conducts the weekly measures and further assessment points	up to the 6 months follow up
Secondary	The proportion of participants that go through the entire treatment period	The proportion of participants that go through the entire treatment period	up to 12 weeks
Secondary	Number of drop-outs from treatment	Number of drop-outs from treatment	up to 12 weeks
Secondary	Participants experience/satisfaction with treatment and assessment procedures through qualitative interviews	Participants experience/satisfaction with treatment and assessment procedures through qualitative interviews	up to the 6-month follow up